Clinical trial
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic…
NCT00008281 · Sanofi, Industry · Unknown status
Key facts
| NCT number | NCT00008281 |
|---|---|
| Title | Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer |
| Official title | A Multicenter, Open-Label, Randomized, Three-Arm Study Of 5-Fluorouracil (5-FU) Plus Leucovorin (LV) Or Oxaliplatin Or A Combination Of (5-Fu) LV + Oxaliplatin As Second-Line Treatment Of Metastatic Colorectal Carcinoma |
| Lead sponsor | Sanofi, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Start date | Oct 1, 2000 |
| First posted | Feb 16, 2004 |
| Last update posted | Jan 6, 2014 |
| Countries | Canada, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: